Tag: Therapeutics
Bone Therapeutics: proposed merger with Medsenic
The orthopedic company Bone Therapeutics announced on Wednesday that it would acquire a majority stake in Medsenic, a ‘biotech’ specializing in autoimmune diseases, in order to expand and diversify its…
Pfizer buys Global Blood Therapeutics
By Jean-Noel Legalland Published on 08/08/2022 at 1:36 p.m. Photo credit © Reuters …
Global Blood Therapeutics, Inc.: Wedbush Lowers Rating to Neutral
Marketzone with MT Newswires 2022 All the news about GLOBAL BLOOD THERAPEUTICS, INC. Analyst Recommendations on GLOBAL BLOOD THERAPEUTICS, INC. …
Pfizer announces acquisition of Global Blood Therapeutics for $5.4 billion
Authorizations from GBT shareholders and the green light from the regulatory authorities are still awaited. The American pharmaceutical group Pfizer announced Monday the acquisition for approximately 5.4 billion dollars of…
Repare Therapeutics Inc.: Goldman Sachs to buy
Marketzone with MT Newswires 2022 All the news about REPARE THERAPEUTICS INC. REPARE THERAPEUTICS INC. Analyst Recommendations 2022 turnover…
Intellia Therapeutics, Inc.: Positive Opinion of Goldman Sachs
Marketzone with MT Newswires 2022 All the news about INTELLIA THERAPEUTICS, INC. Analyst Recommendations for INTELLIA THERAPEUTICS, INC. 2022…
Relay Therapeutics, Inc.: Goldman Sachs remains long
Marketzone with MT Newswires 2022 All the news on RELAY THERAPEUTICS, INC. Analyst Recommendations on RELAY THERAPEUTICS, INC. 2022…
SpringWorks Therapeutics, Inc.: Goldman Sachs continues to buy
Marketzone with MT Newswires 2022 All the news about SPRINGWORKS THERAPEUTICS, INC. 08/05 SPRINGWORKS THERAPEUTICS, INC. : Goldman Sachs continues to buy…
Ipsen signs a strategic partnership with Marengo Therapeutics – 08/01/2022 at 08:46
(AOF) – Ipsen and Marengo Therapeutics have entered into a strategic partnership to develop two preclinical candidate treatments in the clinical phase from Marengo’s STAR platform. This collaboration will benefit…
Ipsen enters partnership with Marengo Therapeutics in immuno-oncology
PARIS (Agefi-Dow Jones)–Pharmaceutical groups Ipsen and Marengo Therapeutics announced on Monday that they have entered into a strategic partnership to develop two clinical-stage precision immuno-oncology treatment candidates. “This collaboration will…
ADC Therapeutics Administers First Patient Dose in Phase 1b Clinical Trial of ADCT-601 Targeting AXL as Monotherapy and in Combination with Gemcitabine in Advanced Solid Tumors
ADCT-601 binds to AXL, a cancer antigen expressed in solid tumors such as sarcomas and associated with resistance to chemotherapy ADCT-601 has been observed to exhibit a manageable safety profile…
Verve Therapeutics, Inc.: Positive Opinion of Guggenheim
Marketzone with MT Newswires 2022 All the news about VERVE THERAPEUTICS, INC. Analyst Recommendations for VERVE THERAPEUTICS, INC. 2022…